PROPOFOL INJECTABLE EMULSION

PROPOFOL INJECTABLE EMULSION was reported 111 times

PROPOFOL INJECTABLE EMULSION is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CENTRAL-ALVEOLAR HYPOVENTILATION 1 0.0222
1 VASCULAR SHUNT 1 0.0172
2 PROPOFOL INFUSION SYNDROME 7 0.0099
3 VENTRICULAR DYSSYNCHRONY 1 0.0090
4 AIRWAY PEAK PRESSURE INCREASED 1 0.0066
5 ENTEROBACTER PNEUMONIA 1 0.0064
6 POSTICTAL PSYCHOSIS 1 0.0064
7 RESPIRATORY PARALYSIS 1 0.0063
8 PNEUMOPERICARDIUM 1 0.0058
9 PHAEOCHROMOCYTOMA CRISIS 1 0.0047
10 MEAN ARTERIAL PRESSURE DECREASED 1 0.0040
11 CARDIO-RESPIRATORY DISTRESS 1 0.0035
12 MYXOEDEMA COMA 1 0.0033
13 DEVICE PROGRAMMING ERROR 1 0.0032
14 NEUROMUSCULAR BLOCK PROLONGED 1 0.0027
15 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 2 0.0019
16 CRYSTAL URINE PRESENT 1 0.0018
17 APNOEIC ATTACK 1 0.0018
18 DIAPHRAGMATIC PARALYSIS 1 0.0017
19 CHOREOATHETOSIS 1 0.0015
20 TRYPTASE INCREASED 1 0.0014
21 SYMPTOM MASKED 1 0.0014
22 HYPERTHERMIA MALIGNANT 2 0.0013
23 SOFT TISSUE INJURY 1 0.0013
24 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 1 0.0013
25 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 4 0.0012
26 ACUTE CHEST SYNDROME 1 0.0011
27 CEREBELLAR ATROPHY 1 0.0011
28 BUNDLE BRANCH BLOCK 1 0.0011
29 DELAYED RECOVERY FROM ANAESTHESIA 1 0.0011
30 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
31 SYSTOLIC DYSFUNCTION 1 0.0009
32 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 1 0.0009
33 DIABETES INSIPIDUS 2 0.0008
34 ANTICHOLINERGIC SYNDROME 1 0.0006
35 RESPIRATORY ALKALOSIS 1 0.0006
36 VASOPLEGIA SYNDROME 1 0.0006
37 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
38 CEREBELLAR INFARCTION 1 0.0006
39 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 3 0.0006
40 PNEUMOMEDIASTINUM 1 0.0006
41 VENTRICULAR ARRHYTHMIA 2 0.0005
42 HYPERTRIGLYCERIDAEMIA 3 0.0005
43 PNEUMONIA STAPHYLOCOCCAL 1 0.0005
44 PULSELESS ELECTRICAL ACTIVITY 2 0.0005
45 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
46 SEROTONIN SYNDROME 8 0.0004
47 PREMATURE RUPTURE OF MEMBRANES 1 0.0004
48 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
49 BRAIN HERNIATION 1 0.0003
50 HYPERCAPNIA 1 0.0003
51 EXPOSURE TO TOXIC AGENT 1 0.0003
52 VENTRICULAR HYPOKINESIA 1 0.0003
53 THROMBOSIS IN DEVICE 1 0.0003
54 BRAIN INJURY 3 0.0003
55 PRIAPISM 1 0.0003
56 HAEMODYNAMIC INSTABILITY 2 0.0003
57 OPTIC ISCHAEMIC NEUROPATHY 1 0.0003
58 RHINOVIRUS INFECTION 1 0.0003
59 APNOEA 2 0.0003
60 TORSADE DE POINTES 2 0.0003
61 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
62 RESPIRATORY ACIDOSIS 1 0.0003
63 VENTRICULAR TACHYCARDIA 4 0.0002
64 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
65 URINE ABNORMALITY 1 0.0002
66 DRUG LEVEL ABOVE THERAPEUTIC 1 0.0002
67 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
68 PULSE ABSENT 1 0.0002
69 HEPARIN-INDUCED THROMBOCYTOPENIA 1 0.0002
70 NORMAL NEWBORN 1 0.0002
71 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
72 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
73 PULMONARY ALVEOLAR HAEMORRHAGE 1 0.0002
74 CIRCULATORY COLLAPSE 3 0.0002
75 STRESS CARDIOMYOPATHY 1 0.0002
76 MYOCLONUS 2 0.0002
77 INFUSION SITE EXTRAVASATION 1 0.0002
78 BRAIN OEDEMA 2 0.0002
79 DYSTONIA 3 0.0002
80 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
81 TACHYPNOEA 2 0.0001
82 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
83 CHROMATURIA 3 0.0001
84 ACIDOSIS 1 0.0001
85 HAEMOLYSIS 1 0.0001
86 ATRIOVENTRICULAR BLOCK 1 0.0001
87 ASPHYXIA 1 0.0001
88 UNRESPONSIVE TO STIMULI 3 0.0001
89 BLOOD MAGNESIUM DECREASED 1 0.0001
90 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
91 CARDIOTOXICITY 1 0.0001
92 PRODUCT QUALITY ISSUE 15 0.0001
93 ATELECTASIS 1 0.0001
94 SINUS BRADYCARDIA 1 0.0001
95 PHARYNGEAL SWELLING 1 0.0001
96 VENTRICULAR EXTRASYSTOLES 1 0.0001
97 RHABDOMYOLYSIS 4 0.0001
98 METABOLIC ACIDOSIS 3 0.0001
99 TACHYCARDIA 8 0.0001
100 VENTRICULAR FIBRILLATION 1 0.0001
101 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
102 CAESAREAN SECTION 1 0.0001
103 HYPOXIA 3 0.0001
104 CARDIAC ARREST 7 0.0001
105 NEUROLEPTIC MALIGNANT SYNDROME 1 0.0001
106 MUSCLE RIGIDITY 1 0.0001
107 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
108 HAIR COLOUR CHANGES 1 0.0001
109 MYDRIASIS 1 0.0001
110 ANAPHYLACTIC SHOCK 2 0.0001
111 BRADYCARDIA 4 0.0001
112 FLUID OVERLOAD 1 0.0001
113 CARDIOMYOPATHY 1 0.0001
114 PNEUMOTHORAX 1 0.0001
115 MUSCLE TIGHTNESS 1 0.0001
116 DELIRIUM 2 0.0001
117 AGITATION 4 0.0001
118 OXYGEN SATURATION DECREASED 3 0.0001
119 HYPOCALCAEMIA 1 0.0001
120 HYPOTENSION 10 0.0000
121 TRANSAMINASES INCREASED 1 0.0000
122 RASH MACULO-PAPULAR 1 0.0000
123 SHOCK 1 0.0000
124 ARRHYTHMIA 2 0.0000
125 HEART RATE INCREASED 4 0.0000
126 EXTRAPYRAMIDAL DISORDER 1 0.0000
127 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
128 DRUG INTERACTION 5 0.0000
129 HYPOTHYROIDISM 1 0.0000
130 HYPERKALAEMIA 1 0.0000
131 DEVICE MALFUNCTION 2 0.0000
132 ACCIDENTAL OVERDOSE 1 0.0000
133 HEPATIC FUNCTION ABNORMAL 1 0.0000
134 SEIZURE 3 0.0000
135 BLINDNESS 1 0.0000
136 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
137 CARDIO-RESPIRATORY ARREST 1 0.0000
138 VAGINAL HAEMORRHAGE 1 0.0000
139 COGNITIVE DISORDER 1 0.0000
140 DRUG INEFFECTIVE 27 0.0000
141 AGGRESSION 1 0.0000
142 PANCREATITIS 1 0.0000
143 OEDEMA 1 0.0000
144 ANAPHYLACTIC REACTION 1 0.0000
145 SEPSIS 2 0.0000
146 TOXICITY TO VARIOUS AGENTS 3 0.0000
147 LETHARGY 1 0.0000
148 SUICIDE ATTEMPT 1 0.0000
149 VERTIGO 1 0.0000
150 EXPOSURE DURING PREGNANCY 1 0.0000
151 BLOOD CREATININE INCREASED 1 0.0000
152 HEPATIC ENZYME INCREASED 1 0.0000
153 RESPIRATORY FAILURE 1 0.0000
154 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
155 TREATMENT FAILURE 1 0.0000
156 DRUG WITHDRAWAL SYNDROME 1 0.0000
157 PULMONARY EMBOLISM 1 0.0000
158 DRUG INTOLERANCE 1 0.0000
159 HYPERTENSION 2 0.0000
160 OVERDOSE 2 0.0000
161 MUSCULAR WEAKNESS 1 0.0000
162 DIZZINESS 4 0.0000
163 RENAL FAILURE 1 0.0000
164 BLOOD PRESSURE INCREASED 1 0.0000
165 ACUTE KIDNEY INJURY 1 0.0000
166 CONFUSIONAL STATE 1 0.0000
167 URTICARIA 1 0.0000
168 HYPERSENSITIVITY 1 0.0000
169 NAUSEA 4 0.0000
170 SOMNOLENCE 1 0.0000
171 ERYTHEMA 1 0.0000
172 CONDITION AGGRAVATED 1 0.0000
173 DYSPNOEA 1 0.0000